Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases. D'Ambrosio D, Freedman MS, Prinz J Ther Adv Chronic Dis. 2016 Jan; 7(1):18-33. PMID: 26770667. Abstract CommentRecommendBookmarkWatch